Technical Analysis for VOR - Vor Biopharma Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | N/A | N/A | Down |
Historical VOR trend table... |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Multiple of Ten Bearish | Other | 0.00% | |
New 52 Week Closing High | Bullish | -16.86% | |
Pocket Pivot | Bullish Swing Setup | -16.86% | |
Multiple of Ten Bullish | Other | -16.86% | |
Bullish Engulfing | Bullish | -15.66% | |
Morning Star | Bullish | -15.66% | |
New 52 Week Closing High | Bullish | -15.66% | |
Multiple of Ten Bullish | Other | -15.66% | |
Hammer Candlestick | Bullish | 3.50% | |
Lizard Bullish | Bullish Day Trade Setup | 3.50% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time | |
---|---|---|
60 Minute Opening Range Breakdown | 2 days ago | |
Fell Below 10 DMA | 2 days ago | |
10 DMA Support | 2 days ago | |
Fell Below Previous Day's Low | 2 days ago | |
Down 10% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
Vor Biopharma, Inc. develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It offers VOR33, an eHSC product candidate that is in preclinical development to treat acute myeloid leukemia (AML). The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML cancer cells. Vor Biopharma, Inc. was incorporated in 2015 and is based in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acute Myeloid Leukemia Therapies For Cancer Tyrosine Kinase Receptors Proteins Haematopoiesis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acute Myeloid Leukemia Therapies For Cancer Tyrosine Kinase Receptors Proteins Haematopoiesis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 63.62 |
52 Week Low | 25.32 |
Average Volume | 322,629 |
200-Day Moving Average | 0.00 |
50-Day Moving Average | 0.00 |
20-Day Moving Average | 0.00 |
10-Day Moving Average | 48.75 |
Average True Range | 9.75 |
ADX | 0.0 |
+DI | 19.30 |
-DI | 12.30 |
Chandelier Exit (Long, 3 ATRs ) | 34.36 |
Chandelier Exit (Short, 3 ATRs ) | 54.58 |
Upper Bollinger Band | 0.00 |
Lower Bollinger Band | 0.00 |
Percent B (%b) | 0.0 |
BandWidth | 0.00 |
MACD Line | 0.76 |
MACD Signal Line | 0.37 |
MACD Histogram | 0.392 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 57.08 | ||||
Resistance 3 (R3) | 57.91 | 54.71 | 55.06 | ||
Resistance 2 (R2) | 54.71 | 51.62 | 54.29 | 54.39 | |
Resistance 1 (R1) | 49.83 | 49.71 | 48.23 | 49.00 | 53.71 |
Pivot Point | 46.63 | 46.63 | 45.83 | 46.21 | 46.63 |
Support 1 (S1) | 41.75 | 43.54 | 40.15 | 40.92 | 36.21 |
Support 2 (S2) | 38.55 | 41.63 | 38.13 | 35.53 | |
Support 3 (S3) | 33.67 | 38.55 | 34.86 | ||
Support 4 (S4) | 32.84 |